ClinicalTrials.Veeva

Menu

OPG-RANKL Levels Around Short Implants

A

Aydin Adnan Menderes University

Status

Completed

Conditions

Short Implant
Implant-abutment Connection
Microleakage

Treatments

Other: Probing depth
Other: Presence of bleeding on probing
Other: Plaque index levels
Other: Crestal bone loss
Other: Peri-implanter sulcus fluid sampling

Study type

Interventional

Funder types

Other

Identifiers

NCT02840773
BAP-03-2014

Details and patient eligibility

About

The aim of the present study was to determine the levels of sRANKL and OPG as well as their relative ratio in PICF surrounding the two different types of implant-abutment connections on short implants after a 12-month monitoring period. Additionally, their association with clinical findings and microbiological markers in plaque samples were assessed in the present study.

Full description

The peri-implant crevicular fluid (PICF) contains several inflammatory mediators; the level of these mediators can provide information on the inflammatory state of the tissue, including the activation of mechanisms of bone destruction. In this context, soluble receptor activator of nuclear factor кB ligand (sRANKL) and osteoprotegerin (OPG) have been suggested as molecular determinants of bone resorption. However, currently, there are only limited studies on the molecular responses of healthy peri-implant tissues following placement of implants on function. The null hypothesis of the present study was that there are no significant differences in the levels of sRANKL and OPG in PICF or in the respective levels of six bacterial species or total bacteria levels in submucosal biofilm samples taken from TIF- and TIS-type implants. Therefore, the aim of the present study was to determine the levels of sRANKL and OPG as well as their relative ratio in PICF surrounding the two different types of implant-abutment connections on short implants after a 12-month monitoring period. Additionally, their association with clinical findings and microbiological markers in plaque samples were assessed in the present study.Thirty short implants were randomly placed in posterior maxillary edentulous sites using a split-mouth design in 15 periodontally healthy subjects. Tapered interference fit (TIF) and taper integrated screwed-in (TIS) types of implant-abutment connections were selected for investigation. PICF and submucosal biofilm samples were collected one month after surgery and repeated 12 months after prosthetic loading. Clinical parameters, including probing depth, dichotomous presence of bleeding on probing, and plaque index, were recorded and digital periapical radiographs were taken at each time point. sRANKL and OPG levels in PICF were analyzed using an enzyme-linked immunosorbent assay. Total bacterial levels, as well as levels of Fusobacterium nucleatum, Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, and Streptococcus oralis, were analyzed in corresponding submucosal biofilm samples using quantitative real-time polymerase chain reaction.

Enrollment

15 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • sufficient bone height for a 6 mm implant and sufficient bone width for a minimum 5.5 mm implant without any augmentation techniques
  • no history of periodontitis.

Exclusion criteria

  • Patients with any systemic diseases
  • Smokers were excluded

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

15 participants in 4 patient groups

Test group-baseline
Active Comparator group
Description:
Press-fit implant connection was monitored at baseline
Treatment:
Other: Plaque index levels
Other: Crestal bone loss
Other: Probing depth
Other: Presence of bleeding on probing
Other: Peri-implanter sulcus fluid sampling
Test group-12 month
Active Comparator group
Description:
Press-fit implant connection was monitored at 12 month after prosthesis delivered.
Treatment:
Other: Plaque index levels
Other: Crestal bone loss
Other: Probing depth
Other: Presence of bleeding on probing
Other: Peri-implanter sulcus fluid sampling
Control group-baseline
Active Comparator group
Description:
Screw-retained connection was monitored at baseline
Treatment:
Other: Plaque index levels
Other: Crestal bone loss
Other: Probing depth
Other: Presence of bleeding on probing
Other: Peri-implanter sulcus fluid sampling
Control group-12 month
Active Comparator group
Description:
Screw-retained connection was monitored at 12 month after prosthesis delivered.
Treatment:
Other: Plaque index levels
Other: Crestal bone loss
Other: Probing depth
Other: Presence of bleeding on probing
Other: Peri-implanter sulcus fluid sampling

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems